Literature DB >> 22678565

Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life.

Francesca Sampogna1, Stefano Tabolli, Damiano Abeni.   

Abstract

Psychosocial problems are frequent among patients with psoriasis. The aim of this study was to analyse the prevalence of some specific psychosocial issues. These were evaluated in 936 patients using the emotions and functioning scales of the Skindex-29 questionnaire. The problems most frequently experienced were: shame, anger, worry, difficulties in daily activities and social life. All problems were associated with the severity of psoriasis and with depression or anxiety. Shame, worry and annoyance were more frequent in women than in men, and shame and anger were associated with a low level of education. Impairment in work/hobbies was significantly higher in patients with palmoplantar psoriasis and those with arthro-pathic psoriasis. In conclusion, clinicians could gain important insights about their patients by looking at the single items of a quality of life instrument, to identify patients with high levels of emotional and social problems, in order to improve quality of care.

Entities:  

Mesh:

Year:  2012        PMID: 22678565     DOI: 10.2340/00015555-1273

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  37 in total

1.  Cost-Effectiveness Analysis of Ixekizumab vs Etanercept and Their Manufacturer-Recommended Dosing Regimens in Moderate to Severe Plaque Psoriasis.

Authors:  Jeremy Udkoff; Lawrence F Eichenfield
Journal:  J Drugs Dermatol       Date:  2017-10-01       Impact factor: 2.114

2.  Prevalence of psoriasis phenotypes among men and women in the USA.

Authors:  J F Merola; T Li; W-Q Li; E Cho; A A Qureshi
Journal:  Clin Exp Dermatol       Date:  2016-02-18       Impact factor: 3.470

3.  Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.

Authors:  Abdul Rahman Khawaja; Syed Muhammad Azam Bokhari; Rasheed Tariq; Shahzad Atif; Hanif Muhammad; Qadeer Faisal; Mohammad Jafferany
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

4.  Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.

Authors:  Emese Herédi; Fanni Rencz; Orsolya Balogh; László Gulácsi; Krisztina Herszényi; Péter Holló; Hajnalka Jókai; Sarolta Kárpáti; Márta Péntek; Éva Remenyik; Andrea Szegedi; Valentin Brodszky
Journal:  Eur J Health Econ       Date:  2014-05-16

5.  Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Authors:  Richard G B Langley; Kristian Reich; Vibeke Strand; Steven R Feldman; Carle Paul; Kenneth Gordon; Richard B Warren; Darryl Toth; Enkeleida Nikaï; Baojin Zhu; Orin Goldblum; Emily Edson-Heredia; Hilde Carlier; Russel Burge; Chen-Yen Lin; Kristin Hollister; Matthias Augustin
Journal:  Qual Life Res       Date:  2019-10-26       Impact factor: 4.147

6.  Relationship Between Skin Shame, Psychological Distress and Quality of Life in Patients with Psoriasis: a Pilot Study.

Authors:  Donja Homayoon; Michaela Hiebler-Ragger; Moritz Zenker; Wolfgang Weger; Human Unterrainer; Elisabeth Aberer
Journal:  Acta Derm Venereol       Date:  2020-07-02       Impact factor: 3.875

7.  Influence of Psoriasis on Household Chores and Time Spent on Skin Care at Home: A Questionnaire Study.

Authors:  Mauri Leino; Anssi Mustonen; Kalle Mattila; Leena Koulu; Risto Tuominen
Journal:  Dermatol Ther (Heidelb)       Date:  2015-05-05

8.  Does illness perception associate with disease symptoms in Behçet's disease?

Authors:  Gonca Mumcu; Fedayi Yağar; Fatma Alibaz-Öner; Nevsun İnanç; Haner Direskeneli; Tulin Ergun
Journal:  Intern Emerg Med       Date:  2018-11-30       Impact factor: 3.397

9.  Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians.

Authors:  H Gilet; A Roborel de Climens; B Arnould; H Bachelez; M Bagot; P Beaulieu; P Joly; D Jullien; M Le Maître; J P Ortonne; C Paul; E Thibout
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-07-25       Impact factor: 6.166

10.  Psoriasis Patients' Knowledge about the Disease and Treatments.

Authors:  Astrid Klopstad Wahl; Torbjørn Moum; Hilde Stendal Robinson; Eva Langeland; Marie Hamilton Larsen; Anne Lene Krogstad
Journal:  Dermatol Res Pract       Date:  2013-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.